Find key information for shareholders in 4D pharma plc
4D pharma plc
9 Bond Court
Leeds LS1 2JZ
For all enquiries please contact email@example.com
There are 109,493,842 ordinary shares in issue. There are no ordinary shares held in treasury. Therefore, the total number of voting rights in the Company is 109,493,842.
Please view the table below for the interests of shareholders of 3% or more which have been notified to the Company.
Insofar as the Company is aware, the percentage of the Company’s issued ordinary shares that is not in public hands is 32.4%.
There are no restrictions as to the transfer of ordinary shares.
|Ordinary shares held||%|
|South Ocean Capital Management and connected parties||11,378,980||10.39%|
|David Robert Norwood||8,557,061||7.82%|
|Duncan Joseph Peyton||7,788,407||7.11%|
|Alexander James Stevenson||7,746,468||7.07%|
|Merck & Co.||7,661,000||7.00%|
|Hargreaves Lansdown Asset Management||6,807,509
|Richard Griffiths and controlled undertakings||5,715,818||5.22%|
This information was last updated as of 24 June 2020.
Meetings and voting
Advisers and registrars
1 Bartholemew Lane
Bryan Garnier & Co. Limited
15 St. Botolph Street
London EC3A 7BB
RSM UK Audit LLP
3 Hardman Street
Manchester M3 3HF
Link Asset Services
34 Beckenham Road
Kent BR3 4TU